Abstract
Developing therapeutics such as neutralizing antibodies targeting the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein is essential to ha......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
